CID 67335295

Iberdomide

Structural Information

Molecular Formula
C25H27N3O5
SMILES
C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5
InChI
InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1
InChIKey
IXZOHGPZAQLIBH-NRFANRHFSA-N
Compound name
(3S)-3-[7-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

29
References

1439
Patents

449.19507 Da
Monoisotopic Mass

1.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 450.20235 210.2
[M+Na]+ 472.18429 222.2
[M+NH4]+ 467.22889 215.2
[M+K]+ 488.15823 217.5
[M-H]- 448.18779 216.0
[M+Na-2H]- 470.16974 213.9
[M]+ 449.19452 213.2
[M]- 449.19562 213.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe